Corporate Governance
Good corporate governance - pointing out corporate directors who should and shouldn't be elected anywhere. This is my attempt to keep track of good people for board of directors and keep track of people who should be avoided.Thursday, November 16, 2006
ISIS Pharma
Thanks to Jim Cramer for pointing this one out.
ISIS Pharma. They put out a press release talking about how good their new experimental drug is. They also says that the drug had a "strong safety profile".
Then they're quarterly report says the drug had some liver issues.
Shame on this company for putting out a press release intended to mislead the investing public.
Who's on this board?
Stanley T Crooke, M.D. Ph.D.
Chairman of the Board and Chief Executive Officer
Isis Pharmaceuticals, Inc.
Spencer R. Berthelsen, M.D.
Chairman and Managing Director
Kelsey-Seybold Clinic
Richard D. DiMarchi, Ph.D.
Professor and the Jack and Linda Gill Distinguished Chair, Biomolecular Science, Indiana University
Joseph Klein, III
Managing Director
Gauss Capital Advisors LLC
Frederick T. Muto, J.D.
Partner
Cooley Godward LLP
B. Lynne Parshall, J.D.
Executive Vice President, Chief Financial Officer and Secretary
Isis Pharmaceuticals, Inc.
John C. Reed, M.D., Ph.D.
President and Chief Executive Officer
The Burnham Institute
Joseph H. Wender
Senior Managing Director
GSC Partners
ISIS Pharma. They put out a press release talking about how good their new experimental drug is. They also says that the drug had a "strong safety profile".
Then they're quarterly report says the drug had some liver issues.
Shame on this company for putting out a press release intended to mislead the investing public.
Who's on this board?
Stanley T Crooke, M.D. Ph.D.
Chairman of the Board and Chief Executive Officer
Isis Pharmaceuticals, Inc.
Spencer R. Berthelsen, M.D.
Chairman and Managing Director
Kelsey-Seybold Clinic
Richard D. DiMarchi, Ph.D.
Professor and the Jack and Linda Gill Distinguished Chair, Biomolecular Science, Indiana University
Joseph Klein, III
Managing Director
Gauss Capital Advisors LLC
Frederick T. Muto, J.D.
Partner
Cooley Godward LLP
B. Lynne Parshall, J.D.
Executive Vice President, Chief Financial Officer and Secretary
Isis Pharmaceuticals, Inc.
John C. Reed, M.D., Ph.D.
President and Chief Executive Officer
The Burnham Institute
Joseph H. Wender
Senior Managing Director
GSC Partners
posted by Larry Diamond # 11:00 PM 
Subscribe to
Posts [Atom]
View mobile version
Archives
August 2006 September 2006 October 2006 November 2006 January 2007 April 2007 May 2007 August 2007 September 2007 October 2007 December 2007 February 2008 March 2008 April 2008 June 2008 July 2008 August 2008 November 2008 February 2009 May 2009 June 2009 July 2009 August 2009
